Guilin Warnover Gene Pharmaceutical Co., Ltd, established on 1999-08-31, Business scope includes eye drops,Gel production and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Bharat Biotech International Ltd. engages in research and development, manufacturing, marketing and distribution of vaccines and biotherapeutics. It focuses on the development of novel health care solutions for region-specific neglected diseases. The firm offers Revac-B+, REGEN-D, HNVAC, COMVAC5, BIOPOLIO, INDIRAB, Typbar TCV, BIOHIB, JENVAC, ROTAVAC and vaccine candidates against chikungunya, chandipura, HPV and Ebola. The company was founded by Krishna Murthy Ella and Suchitra K. Ella in 1996 and is headquartered in Hyderabad, India..

Shaanxi HuiKang Bio-tech is an advocate of biological original medicine and an innovator in the field of medical skincare.

Shenzhen City Rongda Biotechnology Co., Ltd. is a high-tech enterprise with biotechnology as the core and TCM meridians as the basic theory, integrating R&D, production, sales, education and service. The company strives to be a leading health service provider in China and is committed to creating a high-end health industry ecosystem. Relying on the high-tech biotechnology of Rongda Health Research Center, Rongda Biology has achieved the successful application of functional peptides and modern biotechnology in the field of beauty and skin care products and sub-health conditioning by pooling the wisdom of experts in various fields such as biological genetic engineering over the years. It has successfully launched seven brands, namely "Jinnas", "Jinyinmei", "Jinshengyuan", "Qingnenas", "Jinyinkang", "Guoyun", and "Rongkangyun", and has established a "5+1+1" health management platform to provide solutions for damaged skin, skin anti-aging, and comprehensive sub-health care. Through 68 major provincial distributors all over the country, the products have entered more than 5000 beauty and sports institutions. The annual sales of the company are growing rapidly every year, and it has become a new enterprise in the domestic middle and high-end health industry. At the same time, the company's production platform has obtained ISO 22716 and US GMPC certification, and its core products have passed the SGS quality standard inspection, among which the health cream series products have also passed the inspection of the General Administration of Quality and Standardization Inspection of the Russian Federation.

Shenzhen Watsin Genetech Ltd. engages in the research, development, manufacture, and sale of biopharmaceutical products and genetic engineering drugs. Its products include genetic engineering products, peptides, recombinant human epidermal growth factor liquid preparation, computer software. The company was founded on April 22, 1997 and is headquartered in Shenzhen, China.

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, production and sales of medical devices and pharmaceuticals. It offers orthopedics, medical aesthetics, wound healing, hemostasis, ophthalmology and anti-adhesion products. The company mainly offers intraocular lens (IOL), ophthalmology and optometry end products, medical sodium hyaluronate, medical chitosan, medical collage sponge, rhEGF amd other related products. Shanghai Haohai Biological Technology was founded on January 24, 2007 and is headquartered in Shanghai, China.

Suzhou HVHA Medical Technology Development Co., Ltd. is a company headquartered in Suzhou, China. The firm manufactures and wholesales medical devices. It was founded in 2009. Yong Liang Feng is currently the CEO of the company.

Beijing Regenerative Biotechnology Research Institute Co., Ltd., established on 2015-10-21, Business scope includes engineering and technology research and experimental development;technology development,Technical Services,technical consulting,technology transfer;software development;Basic software service;Application software service.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Biotech Pharmaceutical Co., Ltd. is a private company headquartered in Beijing, China, that develops and produces monoclonal antibodies and therapeutic vaccines. It was founded in 2000.

Beijing Jipulin Biotechnology Co., Ltd., established on 2005-04-25, Business scope includes research,develop food,New Drugs and Genetic Engineering Vaccines,Biomedical Materials and Products,Bioengineering and Biomedical Engineering Technology,Breeding technology of excellent breeding stock and poultry,biological feed,protein feed;Provide technology transfer,technical consulting,Technical Services.(Non-monetary contribution1833.33ten thousand RMB,non-patent technology.;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments.)

Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

Founded in 1970, The University of Louisville Foundation, Inc. is an independent charitable located in Louisville, Kentucky. The Foundation is a subsidiary of the University of Louisville and oversees funds donated to the University.

Tianjin Guanqin Pharmaceutical Technology Co., Ltd. engages in the provision of preclinical and clinical services. It offers pre-clinical research, clinical research, third-party audits, pharmacovigilance, and other technical services in the drug development process. The company was founded on November 28, 2007 and is headquartered in Tianjin, China.

Guangzhou Saliai Stemcell Science & Technology Co., Ltd. engages in the provision of stem cell storage, health supplements, biological products, and related health management services. It involves in the production of regenerative medicine devices, medical nutrition supplements, and biological & medical cosmetic products. It operates a research and development platform which includes life bank, health management center, medical center, and medical cell center. The company was founded by Hai Jia Chen and Ming Jia Chen on July 7, 2009 and is headquartered in Guangzhou, China.

Tianjin Minxiang Biomedical Co., Ltd. (stock code: 834738) was founded in 2005 with registered capital of ¥67.3 million. It is a high-tech enterprise that engages in researching, developing and manufacturing biological medicines, chemical raw medicines, preparations, intermediates, and new drugs. The company has many R&D staffs in chemical synthesis, development of chemical technology, detection and quality analysis. Moreover, the company has hired some experts to offering guidance in the fields of information collection, R&D, and scientific research cooperation.

Guangzhou Jishengyuan Biotechnology Co., Ltd., established on 2012-09-12, Business scope includes natural science research and experimental development;Cosmetics Wholesale;Cosmetics Retail;Daily necessities sales;Fermentation process optimization technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Human stem cell technology development and application;Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Bio-feed R&D;R&D of industrial enzyme preparations;Biochemical product technology research and development;General merchandise sales;Technology Import and Export;Import and export;Cosmetic production;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;food production

Guangdong Yuankang Regenerative Medicine Technology Development Co., Ltd., established on 2017-11-22, Business scope includes regenerative medicine technology and cell tissue engineering technology promotion services;Medical Research and Experimental Development;Quality inspection technical service;Biopharmaceutical Manufacturing;Sanitary materials and medical supplies manufacturing;Medical equipment and equipment manufacturing;Other professional consultation;Wholesale and retail of medical supplies and equipment,Wholesale and retail trade.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Sine Pharmaceutical Co. Ltd., part of Shanghai Pharmaceuticals Holding Co., Ltd., is a company headquartered in Shanghai, China, that manufactures and distributes pharmaceutical products. On February 03, 2010 Shanghai Pharmaceuticals Holding Co., Ltd. acquired Shanghai Sine Pharmaceutical Co. Ltd. from Shanghai Pharmaceutical (Group) Co., Ltd. for $124.70 million.

ICell Bioscience Inc (Shanghai) is a high-tech enterprise focusing on the R&D and production of high-quality human tissue source and animal tissue source primary cells, cell lines, iPS cells and other products, and providing outsourcing of professional technical services. The company is headquartered in Shanghai. Sabekang has gathered many high-end professional and technical talents with profound attainments and rich experience in the field of cell biology at home and abroad, has advanced technology research and development in the field of primary cells and iPS cells, gradually carries out extensive international cooperation in the cell industry cluster, has introduced a full set of experimental equipment in the field of life sciences, established a first-class production and research and development laboratory, and adopted international advanced industrial technical standards, manufacturing processes Quality inspection process, high qualification rate of products, professional and efficient technical services before and after sales, and perfect user experience. Adhering to the good wish of industrialization of cell culture, Sabekang people have been actively collecting and storing high-quality tissue samples (including fresh tissue samples in vitro after human medical surgery and tissue samples containing some delicate cells) for many years, separating various precious primary cells from them and freezing them with liquid nitrogen. Up to now, a complete "primary cell bank and cell line bank of human tissue origin" has been established in China. At the same time, the company also actively introduced funds from various sources to build a comprehensive research and development platform, and strive to take the lead in leading the scientific research process of China's iPS cells. Now it has established a good cooperative relationship with many universities, research institutes and pharmaceutical giants at home and abroad. With the advantages of advanced original technology in the field of primary cells, it is becoming an honest partner and strong technical support backing for many biomedical enterprises.